Literature DB >> 17212818

Acute leukaemoid reaction following cardiac surgery.

Nigel E Drury1, Ayyaz Ali, Shafi Mussa, Stephen T Webb, Kanchan P Rege, John Wallwork.   

Abstract

Chronic myelomonocytic leukaemia is an atypical myeloproliferative disorder with a natural history of progression to acute myeloid leukaemia, a complex and poorly understood response by the bone marrow to stress. Cardiac surgery activates many inflammatory cascades and may precipitate a systemic inflammatory response syndrome. We present a case of undiagnosed chronic myelomonocytic leukaemia who developed rapidly fatal multi-organ dysfunction following cardiac surgery due to an acute leukaemoid reaction.

Entities:  

Mesh:

Year:  2007        PMID: 17212818      PMCID: PMC1774565          DOI: 10.1186/1749-8090-2-3

Source DB:  PubMed          Journal:  J Cardiothorac Surg        ISSN: 1749-8090            Impact factor:   1.637


  8 in total

Review 1.  Inflammatory response to cardiopulmonary bypass.

Authors:  Jerrold H Levy; Kenichi A Tanaka
Journal:  Ann Thorac Surg       Date:  2003-02       Impact factor: 4.330

2.  Impact of malignant hematological disorders on cardiac surgery.

Authors:  S Christiansen; C Schmid; A Löher; H H Scheld
Journal:  Cardiovasc Surg       Date:  2000-03

3.  Acute myelogenous leukemia: implications of acute blast crisis and cardiopulmonary bypass.

Authors:  R J Franiak; D A Schwinn
Journal:  J Cardiothorac Vasc Anesth       Date:  1993-08       Impact factor: 2.628

Review 4.  Atypical myeloproliferative disorders: diagnosis and management.

Authors:  Ayalew Tefferi; Michelle A Elliott; Animesh Pardanani
Journal:  Mayo Clin Proc       Date:  2006-04       Impact factor: 7.616

5.  Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study.

Authors:  Evgenij V Potapov; Heinz R Zurbrügg; Corinna Herzke; Stefanie Srock; Hanno Riess; Ralf Sodian; Sabine Hübler; Roland Hetzer
Journal:  Ann Thorac Surg       Date:  2002-08       Impact factor: 4.330

6.  Risk assessment in chronic myelomonocytic leukemia (CMML).

Authors:  U Germing; A Kündgen; N Gattermann
Journal:  Leuk Lymphoma       Date:  2004-07

7.  Off-pump coronary artery bypass grafting in a patient with chronic myelomonocytic leukemia.

Authors:  Kazuhiro Ito; Hideyuki Kawachi; Katsuhiko Nishiyama; Hitoshi Yaku; Nobuo Kitamura
Journal:  Jpn Heart J       Date:  2003-05

8.  Cardiac operations in patients with hematologic malignancies.

Authors:  Alison M Fecher; Thomas J Birdas; David Haybron; Pavlos K Papasavas; Debbie Evers; Philip F Caushaj
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

  8 in total
  5 in total

1.  Can cardiac surgery be performed safely on patients with haematological malignancies.

Authors:  A Guler; M A Sahin; F Cingoz; E Ozal; U Demirkilic; M Arslan
Journal:  Cardiovasc J Afr       Date:  2012-05       Impact factor: 1.167

2.  Urgent Coronary Artery Bypass Surgery in a Patient with Postinfarction Angina and Active Myelomonocytic Leukaemia.

Authors:  Samuel Anthony Galea; Joseph Galea
Journal:  Case Rep Oncol       Date:  2016-11-18

3.  Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction.

Authors:  Megan Melody; Emily Butts; David Menke; Kevin Landolfo; Keith Oken; Taimur Sher; Sharad Khurana
Journal:  Leuk Res Rep       Date:  2020-11-04

4.  Post-operative hyperleukocytosis and leukostasis as the initial presentation of chronic myelomonocytic leukemia: A case report and review of literature.

Authors:  Sumit Gaur; Alexander Philipovskiy; Attilio Orazi
Journal:  Leuk Res Rep       Date:  2021-11-29

5.  Acute Myeloid Leukemia With Central Nervous System Involvement Following Routine Surgical Procedures: A Bridge Between Surgical, Medical, and Neurological Critical Care.

Authors:  Mansur Assaad; Vishal Kumar; Austin Carmack; Apurwa Karki; Daniel Golden
Journal:  Cureus       Date:  2022-01-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.